Mycobacterium abscessus Clearance by Neutrophils Is Independent of Autophagy
- 21 July 2020
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 88 (8)
Abstract
Mycobacterium abscessus, a rapidly growing nontuberculous mycobacteria, is increasingly prevalent in chronic lung disease, including cystic fibrosis, and infections are characterized by neutrophil-dominated environments. However, mechanisms of immune control are poorly understood. Azithromycin, a macrolide antibiotic with immunomodulatory effects, is used to treat M. abscessus infections. Recently, inhibition of macrophage bactericidal autophagy was described for azithromycin, which could be detrimental to the host. Therefore, we explored the role of autophagy in mycobactericidal in neutrophils. Azithromycin did not affect M. abscessus-induced neutrophil reactive oxygen species formation, phagocytosis, or cytokine secretion, and neutrophils treated with azithromycin killed M. abscessus equally well as untreated neutrophils from either healthy or cystic fibrosis subjects. One clinical isolate was killed more effectively in azithromycin-treated neutrophils, suggesting that pathogen-specific factors may interact with an azithromycin-sensitive pathway. Chloroquine and rapamycin, an inhibitor and an activator of autophagy, respectively, also failed to affect mycobactericidal activity, suggesting that autophagy was not involved. However, wortmannin, an inhibitor of intracellular trafficking, inhibited mycobactericidal activity, but as a result of inhibiting phagocytosis. The effects of these autophagy-modifying agents and azithromycin in neutrophils from healthy subjects were similar between the smooth and rough morphotypes of M. abscessus. However, in cystic fibrosis neutrophils wortmannin inhibited killing of a rough clinical isolate and not a smooth isolate, suggesting that unique host-pathogen interactions exist in cystic fibrosis. These studies increase our understanding of M. abscessus virulence and of neutrophil mycobactericidal mechanisms. Insight into the immune control of M. abscessus may provide novel targets of therapy.Keywords
Funding Information
- HHS | National Institutes of Health (NCATS Colorado CTSA)
- Cystic Fibrosis Foundation (MALCOL14G0)
- Cystic Fibrosis Foundation (Colorado NTM Research Development Program)
- Cystic Fibrosis Foundation (POHL16F0)
This publication has 69 references indexed in Scilit:
- Mycobacterium abscessus Glycopeptidolipid Prevents Respiratory Epithelial TLR2 Signaling as Measured by HβD2 Gene Expression and IL-8 ReleasePLOS ONE, 2011
- Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infectionJournal of Clinical Investigation, 2011
- An oxidative environment promotes growth of Mycobacterium abscessusFree Radical Biology and Medicine, 2010
- Azithromycin Alters Macrophage Phenotype and Pulmonary Compartmentalization during Lung Infection withPseudomonasAntimicrobial Agents and Chemotherapy, 2010
- Non-Opsonic Phagocytosis of Legionella pneumophila by Macrophages Is Mediated by Phosphatidylinositol 3-KinasePLOS ONE, 2008
- Mycobacterium abscessus and M. avium Trigger Toll-Like Receptor 2 and Distinct Cytokine Response in Human CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- ATP-induced autophagy is associated with rapid killing of intracellular mycobacteria within human monocytes/macrophagesBMC Immunology, 2008
- Importance of T Cells, Gamma Interferon, and Tumor Necrosis Factor in Immune Control of the Rapid GrowerMycobacterium abscessusin C57BL/6 MiceInfection and Immunity, 2007
- Hypervirulence of a Rough Variant of the Mycobacterium abscessus Type StrainInfection and Immunity, 2007
- Mycobacterium tuberculosisglycosylated phosphatidylinositol causes phagosome maturation arrestProceedings of the National Academy of Sciences of the United States of America, 2003